Trial Information

Summary: Clinical drug trial with Brain Imaging (fMRI) in Healthy and IBS Women

Females between the ages of 18-64 and either have Irritable Bowel Syndrome (IBS) or are a healthy adult are needed to participate in a research study conducted by Dr. Emeran Mayer at the UCLA Center for Neurovisceral Sciences & Women’s Health.

The Purpose of this research study is to determine the effects of a new experimental drug on the brain’s response to various tasks using MRI. This drug is being evaluated for the treatment of conditions such as IBS, anxiety and other dysfunctions.

Qualified volunteers will be compensated up to $1050 upon completion of the study.

Please call (310)312-9381 and refer to GSK - GW008 study.

Patient Inclusion Criteria:
Women, ages 18-64, with clinical diagnosis of IBS guided by ROME II criteria. Right handed. Subjects with IBS age 50 or older must provide evidence of normal colonoscopy. No current smoking history, illicit drug use or psychiatric history.

Patient Exclusion Criteria:
Please call for phone screen

If you would like to learn more about participating in this study, please send an e-mail message using the form below.